secwatch.observer — SEC 8-K summary
======================================

Issuer:     MADRIGAL PHARMACEUTICALS, INC. (MDGL)
CIK:        0001157601
Form:       8-K
Filed at:   2023-09-25T23:59:59+00:00
Accession:  0001193125-23-241315
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Madrigal CCO Remy Sukhija departs; receives 12-month severance, bonus, option acceleration
--------------------------------------------------------------------------------

- Chief Commercial Officer Remy Sukhija leaves to pursue other opportunities, effective immediately.
- Separation includes 12 months base salary and 40% target bonus paid over 12 months.
- Stock options for 28,500 shares accelerated, becoming exercisable immediately.
- Medical benefit coverage continued for 12 months post-departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523241315/0001193125-23-241315-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157601/000119312523241315/d684437d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-241315

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer